Official product information
Sciatica Pro Ingredients: All Ten, With Their Printed Amounts
All ten ingredients from the Supplement Facts panel, in printed order, each with its printed amount, the part the panel names, its %DV where it has one, whether a federal consumer fact sheet covers it and whether a named clinical trial was supplied for it.
Quick answer
The panel lists ten ingredients and prints a separate amount for every one of them: there is no proprietary blend on this label. Four rows are vitamins with a %DV and a NIH fact sheet, and all four percentages are arithmetically correct. Three rows carry a named clinical trial, and all three of those trials were run in diabetic neuropathy rather than in sciatica. Three rows are dried plant powders at 25 mg each, for which no federal consumer page gives an amount.
10 of 10 rows with their own printed amount
Ten ingredients, and an amount printed beside every one
There is no proprietary blend on this bottle, so every amount on this page is quoted rather than derived.
Start with the thing this label does right, because it is unusual enough to lead with. There is no proprietary blend on this bottle. The Supplement Facts panel lists ten ingredients and prints a separate amount for every single one of them: vitamin D3 at 20 mcg, vitamin B6 at 1.7 mg, folate at 383 mcg DFE, vitamin B12 at 2 mcg, alpha lipoic acid at 400 mg, benfotiamine at 150 mg, acetyl L-carnitine at 50 mg, and ashwagandha, broccoli and turmeric powders at 25 mg each. Ten rows, ten figures, no blend line and nothing pooled.
Here is the panel order, with the printed figure beside each row, exactly as the photograph shows it.
- Vitamin D3 (as Cholecalciferol) — 20 mcg
- Vitamin B6 (as Pyridoxine hydrochloride) — 1.7 mg
- Folate — 383 mcg DFE (230 mcg folic acid)
- Vitamin B12 (as Methylcobalamin) — 2 mcg
- Alpha Lipoic Acid — 400 mg
- Benfotiamine — 150 mg
- Acetyl L-Carnitine — 50 mg
- Ashwagandha Powder (Root) — 25 mg
- Broccoli Powder (Brassica Oleracea)(leaf) — 25 mg
- Turmeric Powder (Root) — 25 mg
Two things follow from that list and they shape this whole page. The first is that nothing on it has to be worked out: 10 rows, 10 figures, and about 677 mg of declared actives in a 2-capsule serving. The second is that the useful question changes. On a label that pools its ingredients the question is what is in there; on this one the question is how much, against what was studied — which is a question a reader can answer with division, and which this site answers row by row.
10 / 4 / 3 printed, covered, studied
Ten printed amounts, four federal fact sheets, three named trials
The same ten rows, counted three honest ways, give three different numbers.
There are three honest ways to read these ten rows, and they give three different counts. Ten of ten carry a printed amount — that is the panel. Four of ten have a NIH Office of Dietary Supplements consumer fact sheet with a recommended amount in it: the four vitamins. Three of ten carry a named clinical trial in the supplied material: alpha lipoic acid, benfotiamine and acetyl L-carnitine. Ten, four, three.
Those three counts are the spine of this page, so here they are as one table: the printed amount, the part or form the panel names, the percentage of the Daily Value where one exists, whether a federal consumer fact sheet covers the row, and whether a named clinical trial was supplied for it.
| Row, as printed | Printed amount | Part or form | %DV | Federal fact sheet | Named clinical trial |
|---|---|---|---|---|---|
| Vitamin D3 (as Cholecalciferol) | 20 mcg | vitamin | 100% | Yes | No |
| Vitamin B6 (as Pyridoxine hydrochloride) | 1.7 mg | vitamin | 100% | Yes | No |
| Folate | 383 mcg DFE (230 mcg folic acid) | vitamin | 96% | Yes | No |
| Vitamin B12 (as Methylcobalamin) | 2 mcg | vitamin | 83% | Yes | No |
| Alpha Lipoic Acid | 400 mg | compound | no Daily Value set | No | Yes — SYDNEY 2, in diabetic neuropathy |
| Benfotiamine | 150 mg | compound | no Daily Value set | No | Yes — a placebo-controlled trial, in diabetic neuropathy |
| Acetyl L-Carnitine | 50 mg | compound | no Daily Value set | No | Yes — a Cochrane review, in diabetic neuropathy |
| Ashwagandha Powder (Root) | 25 mg | root powder | no Daily Value set | No | No |
| Broccoli Powder (Brassica Oleracea)(leaf) | 25 mg | leaf powder | no Daily Value set | No | No |
| Turmeric Powder (Root) | 25 mg | root powder | no Daily Value set | No | No |
Nothing in the amount column is derived. Every figure is quoted from the photographed panel, which prints an amount for all ten rows. The four rows with no %DV carry the panel’s own footnote instead: “** Daily Value (DV) not established.”.
Read the last two columns together. Four rows can be checked against a federal recommendation — the four vitamins, and all four of their percentages are worked through on the panel page. Three rows can be checked against a published trial, and the comparison is drawn on the ten amounts page. Three rows can be checked against nothing at all, because no federal consumer page gives an amount for them for nerve pain.
01 The ten dossiers
The ten dossiers, row by row
Every amount chip on these cards is a printed figure, not a bound and not an estimate.
Ten dossiers follow, in panel order. Each one opens to what the row is, the printed amount and why the panel can print it, what reference amount it can be set against, the federal coverage, the trial if there is one, and the caution if one is published.
No ingredient photograph was supplied for any of the ten, so these cards carry no pictures rather than a stock image of a root that was never in a bottle.
20 mcg Vitamin D3 (as Cholecalciferol) printed, 100% DV Row 1 of 10 · vitamin · 100% of the Daily Value
What it is. Cholecalciferol, the form of vitamin D used in most supplements, printed at 20 mcg a serving. That is 100% of the Daily Value, and the Daily Value and the printed amount agree to the microgram.
Why that amount. Printed on the panel as 20 mcg at 100% of the Daily Value. The arithmetic checks: the Daily Value is 20 mcg, and 20 divided by 20 is 100%.
Against what. ODS gives an RDA of 15 mcg (600 IU) for adults 19–70 and 20 mcg (800 IU) for 71 and over; no studied amount for nerve pain.
Federal coverage. A federal consumer fact sheet covers this row: NIH Office of Dietary Supplements, Vitamin D — Consumer. Trial. No named clinical trial was supplied for this row.
Caution. The upper limit is 100 mcg (4,000 IU) a day from all sources. At 20 mcg this row leaves room for the rest of your diet, but it is worth knowing about if you already take a separate vitamin D supplement.
Printed amount, federal fact sheet
1.7 mg Vitamin B6 (as Pyridoxine hydrochloride) printed, 100% DV Row 2 of 10 · vitamin · 100% of the Daily Value
What it is. Pyridoxine hydrochloride at 1.7 mg a serving — the top of the adult RDA range and exactly 100% of the Daily Value, with nothing added for show.
Why that amount. Printed on the panel as 1.7 mg at 100% of the Daily Value. The arithmetic checks: the Daily Value is 1.7 mg, and 1.7 divided by 1.7 is 100%.
Against what. ODS gives an RDA of 1.3 mg (19–50), 1.7 mg (men 51+) and 1.5 mg (women 51+), with an upper limit of 100 mg; no studied amount for nerve pain.
Federal coverage. A federal consumer fact sheet covers this row: NIH Office of Dietary Supplements, Vitamin B6 — Consumer. Trial. No named clinical trial was supplied for this row.
Caution. The risk here is cumulative and it comes from stacking. If you take a B-complex, an energy drink or another multivitamin alongside this, add the B6 across all of them, and keep the total well clear of the limits above.
Printed amount, and the best decision on the panel
383 mcg DFE Folate (230 mcg folic acid) — printed, 96% DV Row 3 of 10 · vitamin · 96% of the Daily Value
What it is. Folic acid, 230 mcg, declared as 383 mcg of dietary folate equivalents. DFE exists because folic acid from a supplement is absorbed better than folate from food, so the two units are not interchangeable milligram for milligram.
Why that amount. Printed on the panel as 383 mcg DFE with 230 mcg of folic acid in brackets. Both the conversion and the percentage check out: ODS gives “240 mcg of folic acid and 400 mcg of folate are both equal to 400 mcg DFE”, a factor of 1.667, so 230 × (400 ÷ 240) = 383.3, which rounds to 383 mcg DFE; and 383 divided by the 400 mcg DFE Daily Value is 95.8%, which rounds to 96%.
Against what. ODS gives an RDA for adults of 400 mcg DFE and an upper limit from supplements and fortified foods of 1,000 mcg; no studied amount for nerve pain.
Federal coverage. A federal consumer fact sheet covers this row: NIH Office of Dietary Supplements, Folate — Consumer. Trial. No named clinical trial was supplied for this row.
Caution. If you have, or suspect, a B12 deficiency, folate is the ingredient to mention to a clinician, because it can correct the blood picture without correcting the nerve damage underneath it.
Printed amount, and the arithmetic checks twice
2 mcg Vitamin B12 (as Methylcobalamin) printed, 83% DV Row 4 of 10 · vitamin · 83% of the Daily Value
What it is. Methylcobalamin at 2 mcg a serving, just under the adult RDA of 2.4 mcg, which is the 83% printed beside it.
Why that amount. Printed on the panel as 2 mcg at 83% of the Daily Value. The arithmetic checks: the Daily Value is 2.4 mcg, and 2 divided by 2.4 is 83.3%, which rounds to 83%.
Against what. ODS gives an RDA for adults of 2.4 mcg and sets no upper limit; no studied amount for nerve pain.
Federal coverage. A federal consumer fact sheet covers this row: NIH Office of Dietary Supplements, Vitamin B12 — Consumer. Trial. No named clinical trial was supplied for this row.
Caution. Reassuring, and ODS says so: “Vitamin B12 has not been shown to cause any harm, even at high doses.” There is no upper limit set for it.
Printed amount, federal fact sheet
400 mg Alpha Lipoic Acid printed Row 5 of 10 · compound · no Daily Value established
What it is. Alpha lipoic acid at 400 mg a serving, printed. At 400 mg it is nearly three fifths of the whole 677 mg of declared actives in a serving, so it is the formula’s centre of gravity.
Why that amount. Printed on the panel as 400 mg with the footnote “** Daily Value (DV) not established.” It is the largest single amount on this label, and it is a printed amount rather than a share of a blend.
Against what. SYDNEY 2 used 600 mg, 1,200 mg and 1,800 mg once daily for five weeks in 181 patients with diabetic distal symmetric polyneuropathy. 400 mg is two-thirds of the 600 mg those authors called optimal in diabetic polyneuropathy.
Federal coverage. No federal consumer fact sheet was supplied for this ingredient. Trial. Yes — SYDNEY 2, in diabetic neuropathy
Caution. No federal consumer fact sheet for alpha lipoic acid was supplied to this desk, so no federal caution, interaction or upper limit is published for it here. Take the panel to a pharmacist rather than a search engine, particularly if you take anything for blood sugar.
Printed amount, trial in diabetic neuropathy
150 mg Benfotiamine printed Row 6 of 10 · compound · no Daily Value established
What it is. Benfotiamine at 150 mg a serving, printed. Benfotiamine is a synthetic derivative of thiamine — worth knowing if you are reading the natural ingredients roundel at the same time.
Why that amount. Printed on the panel as 150 mg with the footnote “** Daily Value (DV) not established.” A printed amount, not a share of a blend.
Against what. A placebo-controlled trial used 300 mg/day and 600 mg/day for six weeks in patients with symmetrical distal diabetic polyneuropathy, 165 randomised. 150 mg is half the lower of those two diabetic-polyneuropathy arms.
Federal coverage. No federal consumer fact sheet was supplied for this ingredient. Trial. Yes — a placebo-controlled trial, in diabetic neuropathy
Caution. No federal consumer fact sheet for benfotiamine was supplied, so no federal caution or interaction is published for it here.
Printed amount, trial in diabetic neuropathy
50 mg Acetyl L-Carnitine printed Row 7 of 10 · compound · no Daily Value established
What it is. Acetyl L-carnitine at 50 mg a serving, printed. It is the third of the three ingredients that give the front-of-bottle phrase “Clinically Studied Ingredients†” its basis.
Why that amount. Printed on the panel as 50 mg with the footnote “** Daily Value (DV) not established.” A printed amount, not a share of a blend.
Against what. A Cochrane review covered four trials and about 906 participants with diabetic peripheral neuropathy at 1,500 mg, 2,000 mg and 3,000 mg a day. 50 mg is one thirtieth of the lowest of those diabetic-neuropathy doses.
Federal coverage. No federal consumer fact sheet was supplied for this ingredient. Trial. Yes — a Cochrane review, in diabetic neuropathy
Caution. No federal consumer fact sheet for acetyl L-carnitine was supplied, so no federal caution or interaction is published for it here.
Printed amount, and the widest gap on the panel
25 mg Ashwagandha Powder (Root) printed Row 8 of 10 · root powder · no Daily Value established
What it is. Ashwagandha root, as a powder rather than an extract, at 25 mg a serving. That is about a fortieth of a gram.
Why that amount. Printed on the panel as 25 mg with the footnote “** Daily Value (DV) not established.” Printed as powder, not as a standardised extract, and no ratio is printed, so 25 mg is 25 mg of dried root.
Against what. No studied amount for nerve pain was supplied for this ingredient.
Federal coverage. No federal consumer page gives an amount for this ingredient for nerve pain. Trial. No named clinical trial was supplied for this row.
Caution. Nothing federal was supplied for ashwagandha specifically, so no federal caution is published for it here. If you take anything daily, the panel goes to a pharmacist.
Printed amount, no federal amount to compare
25 mg Broccoli Powder (Brassica Oleracea)(leaf) printed Row 9 of 10 · leaf powder · no Daily Value established
What it is. Broccoli, printed as Brassica Oleracea and as leaf, at 25 mg a serving. Twenty-five milligrams of dried leaf powder is a very small amount of a vegetable: a single floret of broccoli weighs a few grams.
Why that amount. Printed on the panel as 25 mg with the footnote “** Daily Value (DV) not established.” The panel prints the part as leaf.
Against what. No studied amount for nerve pain was supplied for this ingredient.
Federal coverage. No federal consumer page gives an amount for this ingredient for nerve pain. Trial. No named clinical trial was supplied for this row.
Caution. Nothing federal was supplied for broccoli powder specifically, so no federal caution is published for it here.
Printed amount, no federal amount to compare
25 mg Turmeric Powder (Root) printed Row 10 of 10 · root powder · no Daily Value established
What it is. Turmeric root, as a powder, at 25 mg a serving. The panel prints no curcumin figure and no extract ratio, so what is declared is 25 mg of dried root and nothing more specific than that.
Why that amount. Printed on the panel as 25 mg with the footnote “** Daily Value (DV) not established.” Printed as powder rather than as a standardised curcumin extract, and no ratio or curcumin percentage is printed.
Against what. No studied amount for nerve pain was supplied for this ingredient.
Federal coverage. No federal consumer page gives an amount for this ingredient for nerve pain. Trial. No named clinical trial was supplied for this row.
Caution. Nothing federal was supplied for turmeric specifically, so no federal caution is published for it here. Turmeric is a common kitchen spice and also a common supplement, so if you take a separate turmeric or curcumin product, this row is worth adding to that total rather than ignoring.
Printed amount, no federal amount to compare
4 of 10 rows with a NIH fact sheet behind them
The four rows a federal fact sheet covers
Vitamin B6 first, because restraint on that row is the most important decision on this panel.
Vitamin B6 is printed at 1.7 mg, which is 100% of the Daily Value and not a milligram more, and on a product sold for nerve symptoms that restraint is the most important decision on the panel. NIH’s Office of Dietary Supplements puts the reason in one sentence: “taking high amounts of vitamin B6 from supplements for a year or longer can cause severe nerve damage”. B6 is the one ingredient here where too much causes the very kind of symptom the product is bought because of. The federal upper limit is 100 mg a day; ODS also notes that EFSA “set an upper limit for vitamin B6 of 12 mg per day for all adults”. The RDA is 1.3 mg for adults 19 to 50, 1.7 mg for men 51 and over and 1.5 mg for women 51 and over — so 1.7 mg is the top of the RDA range and a fraction of either limit. Give the formulator credit for it.
Folate is printed at 383 mcg DFE (230 mcg folic acid) against an RDA for adults of “400 mcg DFE”, which is the 96% on the panel. The upper limit for folate from supplements and fortified foods for adults 19 and over is 1,000 mcg, so this row is at well under half of it — and that has to be said first, or the next point misleads. ODS: “Taking large amounts of folate supplements might hide a vitamin B12 deficiency because these supplements can correct the anemia that the vitamin B12 deficiency causes but not the nerve damage”, and “Large doses of folate supplements might also worsen the symptoms of vitamin B12 deficiency.” 383 mcg DFE is not a large dose. The masking point belongs on this page because the product is taken for nerve symptoms and because the same capsule also carries B12; it does not belong here as an alarm about this amount.
The other two vitamins, briefly and in both directions. Vitamin B12 at 2 mcg sits just under the adult RDA of “2.4 mcg”, which is the 83% printed beside it. ODS is direct about why B12 appears on a nerve product at all: “Vitamin B12 deficiency can damage the nervous system even in people who don’t have megaloblastic anemia.” It is equally direct about the limits of supplementing when you are not deficient: on energy, “vitamin B12 doesn’t provide these benefits in people who get enough B12 from their diet.” On safety it is reassuring: “Vitamin B12 has not been shown to cause any harm, even at high doses.” Vitamin D3 at 20 mcg is 100% of the Daily Value, which is the RDA for adults 71 and over (“20 mcg (800 IU)”) and a third more than the RDA for adults 19 to 70 (“15 mcg (600 IU)”). The upper limit is “100 mcg (4,000 IU)”, so this row is at a fifth of it. ODS does not say vitamin D supplements help pain, and on multiple sclerosis — a disease of the nerves — it says “taking vitamin D supplements does not keep symptoms from getting worse or coming back.”
3 of 10 rows with a trial, all of them in diabetic neuropathy
The three rows with a named clinical trial
The claim on the front says studied. It does not say studied in sciatica.
The front of the bottle prints “Clinically Studied Ingredients†”, and that sentence is checkable, so this site checks it. It is true of three rows out of ten. Each of the three has a named trial behind it, each of those trials used more than this label prints, and every one of them was run in diabetic neuropathy — nerve damage from high blood sugar, which is not the condition on the front of the bottle.
| Row | Printed here | Studied amount | Condition studied | The conclusion, verbatim |
|---|---|---|---|---|
| Alpha Lipoic Acid | 400 mg | 600 mg once daily | diabetic distal symmetric polyneuropathy | “An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.” |
| Benfotiamine | 150 mg | 300 mg a day | symmetrical distal diabetic polyneuropathy | “Benfotiamine may extend the treatment option for patients with diabetic polyneuropathy.” |
| Acetyl L-Carnitine | 50 mg | 1,500 mg a day | diabetic peripheral neuropathy | “We are uncertain whether ALC reduces pain in DPN, as the evidence is sparse and of very low certainty.” |
None of these trials was carried out in sciatica. The fractions — two thirds, one half, one thirtieth — are drawn out on the ten amounts page.
Hold the two halves of that together, because dropping either one misleads. The trials are real, published and named, and the amounts on this label are smaller than the amounts they used. The condition they were run in is a different condition from the one this product is named after. An ingredient studied in one nerve condition is not thereby useless in another; it is untested there, and untested is the accurate word.
25 mg each, printed, three times over
The three rows at twenty-five milligrams
Present, printed and small. No federal page gives an amount to set them against, so this site assigns them no effect.
Three rows are printed at 25 mg each: ashwagandha powder (root), broccoli powder, turmeric powder (root). No federal consumer page gives an amount for any of the three for nerve pain, so there is no figure to set 25 mg against and this site assigns them no effect. What can be said is what the panel says: they are present, they are printed, and 25 mg is a small amount of a dried powder — about a fortieth of a gram. All three are listed as powder rather than as standardised extract, and no ratio is printed, so 25 mg is 25 mg.
One absence is worth naming, because on many labels it is where the real argument hides. No extract ratio, concentration or dry-weight equivalence is printed for any row on this panel. The three botanical rows are printed as powder — ashwagandha powder, broccoli powder, turmeric powder — not as standardised extracts, and no footnote converts them into anything else. On a blend label that silence would matter. Here it does not, because the amount is already printed: 25 mg of powder is 25 mg of powder, and there is nothing for a ratio footnote to rescue.
02 The credit, and the two absences
What this panel gets right, and what it leaves out
A label that prints every amount has done the hard part. It has not thereby supplied evidence.
The direction of the gap is the opposite of the usual one, and it should be said plainly. The marketing here is not naming ingredients the bottle does not contain, and the bottle is not hiding ingredients the marketing names. The panel is the most complete surface on this product and it tells you everything. The gap is not in disclosure. It is in evidence: the front of the bottle says “Clinically Studied Ingredients†”, and that sentence is true of three rows out of ten — at amounts larger than these, in a different nerve condition from the one the product is named after.
So the credit and the gap sit in different columns of the same table. The panel is the most complete surface on this product: ten rows, ten figures, the parts named, the footnote printed, and a 1.7 mg vitamin B6 row that a less careful formulator would have printed at fifty times that for the look of it. What the panel cannot supply is evidence, and two absences are worth naming rather than leaving to inference.
Four of the seven are vitamins with a federal recommended intake, which is a reference amount for a diet rather than a studied dose for nerve pain. The other three are the 25 mg powders, for which no federal consumer page gives an amount for nerve pain at all.
Alpha lipoic acid, benfotiamine and acetyl L-carnitine carry the trials on this label and between them carry 600 mg of its 677 mg. None of the three arrived with a federal consumer fact sheet, so no federal caution, interaction or upper limit is published for them on this site. That is a reason to take the panel to a pharmacist rather than to a search engine.
Questions
Sciatica Pro FAQ: ingredients questions
What are the ingredients in Sciatica Pro?
Ten, each with its own printed amount: vitamin D3 20 mcg, vitamin B6 1.7 mg, folate 383 mcg DFE (230 mcg folic acid), vitamin B12 2 mcg, alpha lipoic acid 400 mg, benfotiamine 150 mg, acetyl L-carnitine 50 mg, and ashwagandha, broccoli and turmeric powders at 25 mg each.
How much of each ingredient is in Sciatica Pro?
All ten amounts are printed on the panel and all ten are listed in the answer above. There is no proprietary blend, so nothing has to be derived, bounded or guessed at. That is the single most unusual thing about this label.
Does Sciatica Pro have a proprietary blend?
No. Every one of the ten rows carries its own figure and nothing is pooled into a total. Say that plainly, because it is rare: a blend prints one number for a group and leaves a reader unable to state any individual amount at all.
How much turmeric, ashwagandha and broccoli are in it?
25 mg each, printed, and all three are declared as powder rather than as standardised extracts with no ratio given. No federal consumer page supplied to this desk gives an amount for any of the three for nerve pain, so this site reports them as present and small and assigns them no effect.
What are the other ingredients in Sciatica Pro?
Verbatim from the label: “Hypromellose (vegetable capsule), Brown Rice Flour, Magnesium Stearate.” The first is the capsule shell, the second is the filler, the third is the flow agent that keeps the fill weight consistent.
How many milligrams of active ingredients are in a serving?
About 677 mg, and because every amount is printed it is an addition rather than an estimate: 400 + 150 + 50 + 25 + 25 + 25 is 675 mg, plus 1.7 mg of B6, plus 20 + 230 + 2 micrograms, which is another 0.252 mg. The folate is counted as the 230 mcg of folic acid actually in the capsule rather than as the 383 mcg DFE equivalence.
References
Sources for this page
- NIH Office of Dietary Supplements. Vitamin D — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Vitamin B6 — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Folate — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Vitamin B12 — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- Ziegler D and others, Diabetes Care. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. pubmed.ncbi.nlm.nih.gov. Accessed October 11, 2026.
- Stracke H and others, Experimental and Clinical Endocrinology & Diabetes. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double-blind, placebo-controlled clinical study. pubmed.ncbi.nlm.nih.gov. Accessed October 11, 2026.
- Cochrane Database of Systematic Reviews. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. www.cochrane.org. Accessed October 11, 2026.
Next
Keep reading
The ten amounts, against what was studied
Printed amount beside studied amount, row by row, with the shortfall drawn.
Read itThe panel, line by line
Every printed line, all four percentages checked, and the working shown.
Read itThe cautions that are published
What the federal fact sheets say about the four rows that have one.
Read itOrder Sciatica Pro from the official page
60 capsules a bottle, two a day, thirty days a bottle. Ten ingredients, ten printed amounts, no proprietary blend, and about 677 mg of declared actives a serving. Price and guarantee are read from the live checkout. Order support +1 (302) 200-3480.
Price and guarantee are read on the checkout page — screenshot it with the date before you pay · ships from inside the US · order support +1 (302) 200-3480